0,969  0,001  Neurotrophic factor enhancer
0,968  0,001  UGT1A4 substrate
0,949  0,001  Cholesterol antagonist
0,935  0,003  Antihypercholesterolemic
0,915  0,003  Cardiovascular analeptic
0,900  0,005  Antineoplastic (breast cancer)
0,900  0,006  Apoptosis agonist
0,869  0,003  Antineoplastic (liver cancer)
0,865  0,005  Antileukemic
0,852  0,009  Antiinflammatory
0,843  0,004  Nitric oxide antagonist
0,842  0,004  UDP-glucuronosyltransferase substrate
0,836  0,004  Antineoplastic (pancreatic cancer)
0,831  0,005  Antineoplastic (colon cancer)
0,830  0,005  Antineoplastic (colorectal cancer)
0,823  0,007  Antineoplastic (lung cancer)
0,793  0,006  Alzheimer's disease treatment
0,759  0,004  Antineoplastic (glioma)
0,751  0,007  Chemopreventive
0,724  0,005  Antineoplastic (brain cancer)
0,718  0,005  Proliferative diseases treatment
0,697  0,004  Antihelmintic
0,697  0,006  Antiparasitic
0,690  0,007  Antineoplastic (cervical cancer)
0,676  0,005  Antineoplastic (glioblastoma multiforme)
0,680  0,023  Transcription factor NF kappa B inhibitor
0,654  0,005  Antineoplastic (sarcoma)
0,635  0,004  Platelet adhesion inhibitor
0,603  0,004  Prostatic (benign) hyperplasia treatment
0,612  0,017  Prostate cancer treatment
0,597  0,003  Neurotrophic factor
0,602  0,011  Antipruritic, allergic
0,604  0,015  Antineoplastic (ovarian cancer)
0,597  0,010  Lipoprotein disorders treatment
0,589  0,013  Antiprotozoal (Plasmodium)
0,585  0,012  Cardioprotectant
0,571  0,013  AR expression inhibitor
0,572  0,015  Cytotoxic
0,566  0,012  Antifungal
0,562  0,007  Antineoplastic (lymphoma)
0,566  0,013  Apoptosis antagonist
0,566  0,023  Antiprotozoal
0,547  0,004  Contraceptive
0,545  0,009  Hypolipemic
0,539  0,004  Dementia treatment
0,538  0,004  Vascular dementia treatment
0,538  0,004  Psychosexual dysfunction treatment
0,538  0,007  Antineoplastic (renal cancer)
0,548  0,019  Sensitization
0,549  0,023  Respiratory analeptic
0,536  0,020  Antineoplastic (melanoma)
0,530  0,016  NOS3 expression inhibitor
0,535  0,024  Immunosuppressant
0,534  0,029  Teratogen
0,526  0,028  Embryotoxic
0,509  0,014  Antipyretic
0,497  0,005  Diabetic nephropathy treatment
0,492  0,005  Prostate disorders treatment
0,483  0,005  Sodium/bile acid cotransporter inhibitor
0,490  0,013  Antihypertriglyceridemic
0,488  0,013  UGT2B4 substrate
0,510  0,039  CYP3A4 substrate
0,488  0,024  Hepatic disorders treatment
0,503  0,046  TNF expression inhibitor
0,461  0,010  Anesthetic general
0,451  0,005  Antiviral (Influenza A)
0,445  0,006  Lipocortins synthesis antagonist
0,443  0,006  Antipruritic, non-allergic
0,460  0,053  Antibacterial
0,432  0,027  Antineoplastic (non-small cell lung cancer)
0,422  0,018  Amyotrophic lateral sclerosis treatment
0,413  0,009  Antiviral (Influenza)
0,427  0,030  ICAM1 expression inhibitor
0,428  0,032  Analeptic
0,404  0,010  Antiacne
0,405  0,011  UGT2B7 substrate
0,403  0,013  Hepatoprotectant
0,405  0,027  Hypoglycemic
0,384  0,009  Hemostatic
0,402  0,035  Antioxidant
0,372  0,007  Growth factor agonist
0,367  0,005  UGT2B9 substrate
0,365  0,007  Antitussive
0,373  0,021  Abortion inducer
0,373  0,041  UGT1A9 substrate
0,328  0,002  RNA-directed RNA polymerase stimulant
0,359  0,033  Antidiabetic symptomatic
0,364  0,040  NOS2 expression inhibitor
0,340  0,016  Anesthetic
0,320  0,006  Androgen antagonist
0,351  0,042  Antineoplastic (multiple myeloma)
0,325  0,027  UGT1A1 substrate
0,297  0,002  Arachidonic acid antagonist
0,310  0,015  Liver fibrosis treatment
0,297  0,006  Contraceptive female
0,293  0,005  UGT2B10 substrate
0,312  0,029  Muscle relaxant
0,293  0,010  Cell adhesion inhibitor
0,302  0,020  Interferon gamma antagonist
0,338  0,057  CYP3A4 inhibitor
0,319  0,047  Platelet antagonist
0,314  0,044  Angiogenesis stimulant
0,281  0,012  Antifungal enhancer
0,287  0,019  UGT2B15 substrate
0,267  0,008  Contraceptive male
0,257  0,001  Cholesterol absorption inhibitor
0,261  0,006  Microtubule formation inhibitor
0,303  0,051  Antiamyloidogenic
0,296  0,046  Amyloid beta aggregation inhibitor
0,253  0,006  Estrogen agonist
0,273  0,029  Thrombolytic
0,364  0,134  Caspase 9 stimulant
0,238  0,009  Beta amyloid protein antagonist
0,230  0,007  Aromatase inhibitor
0,228  0,009  Growth stimulant
0,304  0,088  Calcium channel activator
0,275  0,059  Cardiodepressant
0,342  0,128  Cyclophilin D inhibitor
0,342  0,128  Antidiabetic
0,293  0,079  Interleukin 2 agonist
0,268  0,054  UGT1A6 substrate
0,275  0,062  Interleukin agonist
0,243  0,032  Antineoplastic (squamous cell carcinoma)
0,268  0,060  Cytostatic
0,260  0,060  DNA synthesis inhibitor
0,233  0,034  Hair growth stimulant
0,211  0,018  Endometrios treatment
0,211  0,019  Antineoplastic antibiotic
0,195  0,005  UGT2B11 substrate
0,197  0,011  Pregnane X receptor agonist
0,189  0,005  Anabolic
0,221  0,038  Antineoplastic (carcinoma)
0,198  0,022  Farnesoid X receptor antagonist
0,260  0,092  Immunostimulant
0,228  0,061  Carcinogenic
0,204  0,040  Toxic, respiratory center
0,187  0,030  Cholesterol synthesis inhibitor
0,162  0,005  Glycine receptor agonist
0,160  0,004  Na+ K+ transporting ATPase inhibitor
0,199  0,058  VEGF expression inhibitor
0,205  0,066  Mutagenic
0,146  0,008  Glycine receptor antagonist
0,183  0,048  NOS3 expression enhancer
0,214  0,081  RNA-directed DNA polymerase inhibitor
0,136  0,008  Anticholelithogenic
0,134  0,009  Androgen agonist
0,137  0,013  Postmenopausal disorders treatment
0,128  0,005  Antitreponemal
0,204  0,082  Antimitotic
0,123  0,003  Lipocortins synthesis agonist
0,125  0,008  5-Alpha-reductase inhibitor
0,140  0,028  Estrogen antagonist
0,191  0,085  Psychostimulant
0,107  0,005  Glucocorticoid antagonist
0,170  0,069  UGT1A3 substrate
0,116  0,017  Premenstrual syndrome treatment
0,134  0,037  UGT2B1 substrate
0,116  0,024  Bile acid receptor antagonist
0,119  0,027  Antibiotic
0,094  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,221  0,135  Bone diseases treatment
0,109  0,023  Lipase inhibitor
0,118  0,034  Estrogen receptor beta antagonist
0,087  0,005  Pregnane X receptor antagonist
0,085  0,010  Mineralocorticoid receptor antagonist
0,120  0,047  Antiinfertility, female
0,122  0,051  Choleretic
0,107  0,043  Antineoplastic alkaloid
0,073  0,012  Progesterone antagonist
0,065  0,004  Progesterone agonist
0,064  0,008  Hypogonadism treatment
0,063  0,006  5-Alpha-reductase 2 inhibitor
0,070  0,016  Estrogen receptor beta agonist
0,136  0,083  Antifungal (Cryptococcus)
0,135  0,086  Genotoxic
0,133  0,085  Skeletal muscle relaxant
0,065  0,018  Anesthetic inhalation
0,155  0,109  P-glycoprotein inhibitor
0,189  0,143  Antineurogenic pain
0,063  0,018  Aldosterone antagonist
0,073  0,029  Antimycoplasmal
0,226  0,182  Antineoplastic (endocrine cancer)
0,059  0,016  Microtubule stabilization
0,045  0,004  Corticosteroid-like
0,096  0,055  SULT1E1 substrate
0,045  0,005  Glucocorticoid agonist
0,088  0,048  Opioid kappa receptor antagonist
0,114  0,076  Alcohol dehydrogenase substrate
0,065  0,027  Postcoital contraceptive
0,053  0,016  Estrogen receptor alpha agonist
0,087  0,050  Antiprotozoal activity enhancer
0,194  0,160  Hypoxia-inducible factor 1 alpha inhibitor
0,065  0,034  Heme oxygenase stimulant
0,161  0,133  Antineoplastic (lymphocytic leukemia)
0,078  0,052  Estrogen receptor alpha antagonist
0,035  0,009  Estrone sulfatase inhibitor
0,094  0,069  Antifibrinolytic
0,033  0,008  5-Alpha-reductase 1 inhibitor
0,068  0,046  Andropause treatment
0,223  0,203  CYP2C19 inhibitor
0,081  0,063  T cell inhibitor
0,156  0,138  Antiprotozoal (Leishmania)
0,037  0,019  Tubulin agonist
0,027  0,010  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,100  0,086  DNA polymerase I inhibitor
0,017  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,046  0,033  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,043  0,030  Opioid kappa receptor agonist
0,069  0,058  CDC25A inhibitor
0,010  0,002  Transcortin receptor antagonist
0,065  0,059  SULT2A1 substrate
0,016  0,011  Vitamin D receptor agonist
0,014  0,012  NMDA receptor phencyclidine site antagonist
0,046  0,045  Protein 50S ribosomal subunit inhibitor

